Beyond Diagnostics
About Beyond Diagnostics
Beyond Diagnostics develops AI-powered point-of-care tests that assess the efficacy of insulin medications in real-time, enabling patients to monitor their treatment at home. This technology addresses the instability of insulin in varying conditions, ensuring that each dose maintains its effectiveness and supports better diabetes management.
```xml <problem> People with diabetes need precise insulin dosing, but insulin's effectiveness can degrade due to real-world storage conditions during treatment at home and on the go. Patients currently lack a way to verify insulin activity levels outside of controlled supply chain environments, potentially leading to life-threatening situations. </problem> <solution> Beyond Diagnostics is developing point-of-care (POC) tests that enable individuals with diabetes to assess the quality and efficacy of their insulin medication in real-time. The tests are designed for use at home, providing patients with direct feedback on whether their insulin has maintained its activity. By ensuring that each dose of insulin delivers its full potential, this technology aims to improve diabetes management and give patients greater confidence in their treatment. The company leverages research on insulin activity to provide a solution for safe and effective insulin therapy. </solution> <features> - POC test to measure insulin activity levels in real-time - Designed for at-home use, enabling convenient and frequent testing - Aims to ensure the efficacy of each insulin dose - Based on research from the Insulin Activity Project at the Diabetes Center Berne </features> <target_audience> The primary target audience includes individuals with diabetes who self-administer insulin and require a method for verifying its effectiveness, as well as healthcare providers managing diabetic patients. </target_audience> ```
What does Beyond Diagnostics do?
Beyond Diagnostics develops AI-powered point-of-care tests that assess the efficacy of insulin medications in real-time, enabling patients to monitor their treatment at home. This technology addresses the instability of insulin in varying conditions, ensuring that each dose maintains its effectiveness and supports better diabetes management.
Where is Beyond Diagnostics located?
Beyond Diagnostics is based in Zürich, Switzerland.
When was Beyond Diagnostics founded?
Beyond Diagnostics was founded in 2023.
- Location
- Zürich, Switzerland
- Founded
- 2023
- Employees
- 1 employees